Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tapetoretinal degenerations: experiences, experiments and expectations.

B Ehinger1

  • 1The Wallenberg Retina Center, Department of Ophthalmology, Lund University Hospital, Sweden. Berndt.Ehinger@oft.lu.se

Acta Ophthalmologica Scandinavica
|July 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplantation of human embryonic retina to adult rat retina.

Restorative neurology and neuroscience·2011
Same author

Multiple neurotransmitter systems influence the release of adenosine derivatives from the rabbit retina.

Neurochemistry international·2010
Same author

Retinal indoleamine accumulating neurons.

Neurochemistry international·2010
Same author

Immunohistochemical and quantitative analysis of 5-hydroxytryptamine in the retina of some vertebrates.

Neurochemistry international·2010
Same author

Simultaneous immunohistochemistry and autoradiography of peptides and 5-hydroxytryptamine in bird retina.

Neurochemistry international·2010
Same author

The uptake of the GABA agonist, [(3)H]isoguvacine, by the isolated retina of the rabbit.

Neurochemistry international·2010
Same journal

Expression of interleukin-6, tumour necrosis factor-alpha and nitric oxides during episodes of ocular toxoplasmosis in an HIV patient.

Acta ophthalmologica Scandinavica·2007
Same journal

Varicella chorioretinitis.

Acta ophthalmologica Scandinavica·2007
Same journal

Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables.

Acta ophthalmologica Scandinavica·2007
Same journal

Solving the enigma of exfoliation glaucoma: a breakthrough in glaucoma research.

Acta ophthalmologica Scandinavica·2007
Same journal

Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up.

Acta ophthalmologica Scandinavica·2007
Same journal

Incidence and prevalence of pseudoexfoliation and open-angle glaucoma in northern Sweden: I. Baseline report.

Acta ophthalmologica Scandinavica·2007
See all related articles

New insights into tapetoretinal degenerations are paving the way for novel treatments. While Vitamin A remains the only current therapy, research is exploring drugs, gene therapy, and cell transplantation for these vision disorders.

Area of Science:

  • Ophthalmology
  • Neurobiology
  • Genetics

Background:

  • Tapetoretinal degenerations are common causes of vision loss.
  • Historically, rational treatment options have been limited.
  • Recent advances in neurobiology and pathobiology are changing this landscape.

Purpose of the Study:

  • To review the current understanding and emerging therapeutic strategies for tapetoretinal degenerations.
  • To highlight the shift from poorly understood disorders to well-defined diseases with increasing research focus.

Main Methods:

  • Review of current and experimental therapeutic strategies.
  • Discussion of pharmacological interventions (e.g., diltiazem).
  • Exploration of genetic and cellular transplantation approaches.

Related Experiment Videos

Main Results:

  • Vitamin A is the only established treatment.
  • Experimental therapies include apoptosis delay, protein variant counteraction, transgene use, and cell/tissue transplantation.
  • Clinical trials for novel strategies are underway.

Conclusions:

  • Significant progress is being made in understanding and treating tapetoretinal degenerations.
  • Future treatments will likely be diverse, including pharmacological, genetic, and transplantation-based approaches.
  • Improved diagnostics and treatments are expected to enhance patient care significantly.